Status:
COMPLETED
Case Managers for CVD Risk Reduction in HIV Clinic
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Disease
HIV
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
The purpose of the study is to assess the efficacy of a case manager/social worker administered, telephone-based educational curriculum in improving cardiovascular disease related outcomes among HIV-i...
Detailed Description
Fifty high Cardiovascular Disease Risk (CVD) risk clinic patients will be randomized 1:1 to receive either a series of educational pamphlets on CVD risk reduction plus a telephone-based CVD risk reduc...
Eligibility Criteria
Inclusion
- In care at the Duke Infectious Diseases Clinic for HIV and for at least 24 months
- On antiretroviral therapy
- 2013 American Heart Association 10-year ASCVD risk score ≥ 15%, with a diagnosis of either hypertension or hyperlipidemia
- English literate (able to speak and read at a 6th grade level)
- Subjects must have the capacity to give legally effective consent.
Exclusion
- Patients with prior diagnosis of acute coronary syndrome, stroke, peripheral vascular disease, and end stage renal disease
Key Trial Info
Start Date :
October 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03839394
Start Date
October 12 2020
End Date
September 14 2023
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27701